Jubilant Pharmova (BOM:530019) FFO


BOM:530019 Jubilant Pharmova Ltd BOM:530019
76 GF Score
Price ₹968.75
GF Value ₹1,054.41
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Jubilant Pharmova FFO?

FFO (Funds from operations) only applies to REITs.

BOM:530019
76GF Score
Jubilant Pharmova Ltd BOM:530019
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jubilant Pharmova (BOM:530019) Overvalued in 2026?

Based on GuruFocus' analysis, Jubilant Pharmova stock appears to be undervalued. The current stock price of ₹968.75 is trading 8.1% below its estimated GF Value™ of ₹1,054.41. GuruFocus considers Jubilant Pharmova to be Fairly Valued.

Key valuation signals for BOM:530019:

  • FFO:
  • GF Value™: ₹1,054.41 vs. price of ₹968.75 (8.1% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the BOM:530019 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jubilant Pharmova Business Description

Other Exchanges JUBLPHARMA:India
Address 1A, Sector 16A, Noida, UP, IND, 201301
Jubilant Pharmova Ltd is an integrated pharmaceutical company. The company operates in the following segments; Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation; and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment which specializes in developing, manufacturing, commercializing, and distributing therapeutic agents in the nuclear medicine domain. Geographically, it derives a majority of its revenue from the Americas and Europe and the rest from India and the Rest of the world.
76GF Score

Get the complete analysis for BOM:530019

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹968.75
Price
₹1,054.41
GF Value